Cargando…
Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study
Breast-conserving therapy was once a contraindication in young breast cancer patients (aged ≤40 years). Emerging studies suggest that breast-conserving therapy and mastectomy could achieve similar prognosis in this population. However, the effect of molecular subtype disparity on surgical strategy i...
Autores principales: | Yu, Ping, Tang, Hailin, Zou, Yutian, Liu, Peng, Tian, Wenwen, Zhang, Kaiming, Xie, Xiaoming, Ye, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480363/ https://www.ncbi.nlm.nih.gov/pubmed/33356518 http://dx.doi.org/10.1177/1073274820976667 |
Ejemplares similares
-
Breast‐conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population‐based study
por: Yu, Ping, et al.
Publicado: (2020) -
Predictive Nomogram of Subsequent Liver Metastasis After Mastectomy or Breast-Conserving Surgery in Patients With Nonmetastatic Breast Cancer
por: Yang, Anli, et al.
Publicado: (2021) -
Breast-conserving therapy versus mastectomy
por: van Maaren, Marissa C., et al.
Publicado: (2016) -
Breast‐conserving surgery versus mastectomy in young women with breast cancer in Asian settings
por: Sinnadurai, S., et al.
Publicado: (2018) -
Survival Outcomes of Breast-Conserving Therapy versus Mastectomy in Early-Stage Breast Cancer, Including Centrally Located Breast Cancer: A SEER-Based Study
por: Yu, Tianshui, et al.
Publicado: (2022)